Holista CollTech joins forces with GICC to develop works first nasal sanitiser, page-417

You have to remember years of R&D costs and accrued losses in the millions to get to commercialization typically result in built in costs post this being very good i.e I wouldn't put it past them for having 80% margins+.... Same with enterprise tech as the source code is scale and replicated.
Once they have the formula it is all about scale.... It might cost them $2 for a $14 product all in maybe $7 so should be extremely profitable with scale... who knows though for this sort of product.... Will start to find out on quarterlies.... What we do know is the company can operate profitably and is multiple sectors so it is passed that point of "Can we sell this mvp at scale" ....

Selfishly hoping no news by mid month so i can top up again - no brainer considering the upside.

$1 by midyear isn't out of the question